An increasing number of expecting parents are making the choice whether to bank their baby’s cord blood. But with several factors and options to consider, many are left still wondering “why are parents saving cord blood and which cord blood bank should I use?”
Banking stem cells is a large decision that often gets complicated after reading cord blood banking reviews and researching stem cell banks. It can seem like everyone is saying the same thing, or even worse, providing contradicting information. Every parent-to-be wants the best for their baby and family and cord blood banking is like an insurance policy that you hope you’ll never need to use. That means choosing the best cord blood bank with highest quality and greatest value for your investment.
Americord® is a leader in the advancement of cord blood, cord tissue, and placenta tissue banking. As one of the only banks to offer placenta tissue banking and the only cord blood bank with Cord Blood 2.0™ technology, Americord® offers top tier quality stem cell banking at a fraction of the cost.
Cord blood contains valuable hematopoietic stem cells (HSCs) that are currently being used to treat over 80 diseases including leukemia, lymphoma, myeloma, immune system disorders, bone marrow cancers, anemias, and more. HSCs can become any of the blood cells and cellular blood components in our bodies (such as white blood cells, red blood cells, platelets, etc.) and they are currently being used to treat over 80 diseases.
In order to collect these valuable stem cells, Americord® developed Cord Blood 2.0™, one of the most groundbreaking advancements in umbilical cord blood banking. Until now, a huge limitation of cord blood banking has been that the number of stem cells that are preserved in a typical cord blood collection are only sufficient to treat someone up to 65 pounds. With Cord Blood 2.0™, up to twice as many stem cells can be collected and saved, making it possible to treat larger patients and expand treatment opportunities for smaller patients. Americord® makes it possible to perform stem cell therapy and stem cell treatments on a child into adolescence and even adulthood. Banking cord blood can now be an insurance policy for life since it is possible to collect enough stem cells to treat children and adults.
More and more parents are also concerned about the potential conflict between delayed cord clamping and cord blood collections. Americord™ believes that parents should be able to do both. Now that it is possible to collect twice as many stem cells, parents can do a cord blood collection after delayed cord clamping that results in a viable collection size and volume while still providing their child with the health benefits of delayed cord clamping. Americord® agrees with the American College of Obstetricians and Gynecologists, which states that delaying cord clamping for 1.5-3 minutes is ideal. When the cord blood collection is begun no later than 3 minutes, the chances of a viable collection size are high.
Along with many other cord blood banks, Americord® offers cord tissue banking along with cord blood banking. However, Americord® is one of the only banks to offer placenta tissue banking. A lot of parents-to-be don’t realize the possibilities for placenta tissue since most cord banking companies still do not offer it as a banking option. Offering placenta tissue banking gives families the ability to bank on Mom too.
Banking your baby’s placenta tissue means saving mesenchymal stem cells (MSCs) that are a genetic match to mom. During pregnancy, the mother’s body uses MSCs to create the placenta, which acts as a barrier between her body and the baby’s. This newly built organ nourishes the growing child throughout pregnancy and provides a filtration system to pass nutrients to the baby that they need After birth, Americord® collects the entire placenta and selects the most valuable portions for storage in order to collect the stem cells that are a genetic match to the mother. With new uses for the placenta on the horizon, moms are choosing to save this incredible organ rather than discard it. Researchers also agree that MSCs, like those from placenta tissue, hold the keys to the future of stem cell treatments and research.
But how much is cord blood banking? Banking cord blood does not have to be out of reach because of cost. Instead of paying doctors for referrals or spending millions on marketing, savings are passed on directly to parents-to-be. With every Americord™ Collection Kit, 20 years of free stem cell storage is included. There are no annual fees, processing fees, or shipping fees. Americord® doesn’t charge anything until after we have given a Certificate of Storage has been sent, confirming that the stem cells are viable and safely stored.
Unlike Cord Blood Registry and Viacord, who both charge yearly for umbilical cord blood banking, Americord® offers both a one time payment and a 24 month payment plan option that covers 20 years of storage. Cord Blood 2.0™ is $2,999 as a one time payment or $139 for 24 months as a payment plan. Americord® firmly believes that each client should have easy and free access to their collection whenever needed. If a family ever needs a cord blood transplant, Americord® will release the cells at no charge and will pay for up to $500 of the shipping cost.
When weighing cord blood banking pros and cons, it’s important to remember that in order for this investment to last a lifetime, enough stem cells will need to be collected and stored to treat the child as he or she grows. Cord blood uses are increasing each year and twenty years ago, there were no diseases treated with these stem cells. In future years, the possible benefits of cord blood banking will likely cover a much larger array of diseases and illnesses. Cord Blood 2.0 protects this investment and provides the best chance to collect more stem cells for future years. Similarly, placenta tissue clinical trials are on the rise and there is data showing enormous potential in treating type 1 diabetes, assisting in stem cell transplants, and alleviating optical disorders. This is a chance to ensure possible treatment options for mom as research progresses and discovers more uses. Reaping the benefits of stem cells from cord blood, cord tissue, and placenta tissue does not have to be out of reach financially. Banking with Americord® means the highest quality banking, innovative stem cell options, and the absolute best value.
AUTHOR: This post was contributed by Americord Registry, a leader in the advancement of umbilical cord blood, cord tissue, and placenta tissue banking.
Future Posts about the Cord Blood Industry
To receive future posts about the cord blood industry, sign-up here. We will never share your information with anyone, and you can opt-out at any time. No spam ever, just great stuff.
BioInformant is the only research firm that has served the stem cell sector since it emerged. Our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and applies these techniques to the field of market research. BioInformant has been featured on news outlets including the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, Beckton Dickinson, and Thermo Fisher Scientific, BioInformant is your global leader in stem cell industry data.
To learn more about emerging trends and findings within the cord blood industry, view the “Complete 2015-16 Global Cord Blood Banking Industry Report” now.